中国恒大(03333.HK):预期延迟刊发2021年经审核业绩
格隆汇3月22日丨中国恒大(03333.HK)发布公吿,由于自去年下半年起公司房地产板块的经营情况发生重大变化,核数师于本年度增加了大量额外的审计程序,再加上新冠疫情的相关影响,根据公司目前掌握的资料,公司无法按期完成审计程序。由于审计工作尚未完成,公司预期无法根据上市规则第13.49(1)条,于2022年3月31日或之前刊发截至2021年12月31日止年度的经审核业绩。
待审计程序完成后,公司将在切实可行情况下尽快发布经公司核数师协议同意的经审核年度业绩。公司将另行刊发公吿通知公司证券持有人及潜在投资者公司预期的业绩发布日期。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.